Skip to main content
. 2010 Dec;51(12):6321–6328. doi: 10.1167/iovs.10-5690

Figure 6.

Figure 6.

Effect of dbcAMP on agonist-stimulated decrease in stimulated Raf-1, MEK, and MAPK activity. Lacrimal gland acini were incubated with dbcAMP (10−3 M) for 30 minutes. The cholinergic agonist carbachol (Cch 10−4 M) or the growth factor EGF (10−7 M) was then added for 5 minutes. Western blot analysis was performed using an antibody against phosphorylated Raf-1 (A), MEK (B), and MAPK (C). Data are mean ± SEM of five independent experiments. *Significant difference from agonist alone. Representative blots (right).